How does radiographic surveillance help differentiate between inflammatory/reactive and neoplastic bone disease?

• A. It allows noninvasive documentation of progression or regression; regression or response to trial treatment suggests a reactive process, while progression of aggressive characteristics suggests malignant neoplasia.
• B. It confirms malignant neoplasia with certainty.
• C. It has no diagnostic value.
• D. It reveals the histology of the lesion.

Answer: (A)

Serial radiographs track how a bone lesion changes over time, which helps distinguish reactive/inflammatory processes from neoplastic ones. In inflammatory or reactive disease, appropriate treatment often leads to regression or stabilization of the lesion; seeing regression on follow-up imaging supports a non-neoplastic process. Conversely, neoplastic lesions, especially malignant ones, tend to progress, with increasing lysis, cortical destruction, or aggressive periosteal reactions on subsequent images, even when initial management is attempted. Radiographic surveillance is valuable because it’s noninvasive and can be repeated to document these patterns, guiding further steps such as biopsy or treatment changes. It cannot, by itself, confirm histology or definitively diagnose malignancy, but the trajectory of change over time provides important diagnostic clues.